Epigenetics Drugs & Diagnostic Technologies Global Market Report … – Business Wire
DUBLIN–(BUSINESS WIRE)–The “Epigenetics Drugs & Diagnostic Technologies Market, by Type and by Region – Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030” report has been added to ResearchAndMarkets.com’s offering.
This report provides an in-depth analysis of the global epigenetics drugs & diagnostic technologies market, market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
Market Dynamics
Increasing prevalence of cancer is expected to drive the market growth during the forecast period.
According to the World Health Organization, cancer is a leading cause of death worldwide, which accounted for around 10 million deaths in 2020. The most common cancer, in terms of new cases of cancer were breast (2.26 million cases), lung (2.21 million cases) and colon & rectum (1.93 million cases).
Epigenetic changes are commonly associated with all human cancers and often responsible for genetic alterations driving the cancer phenotype. The changes includes histone modifiers and readers, Deoxyribonucleic acid (DNA) methylation, chromatin remodelers, and other components of chromatin. The epigenetic changes can lead to mutations in genes which eventually causes modification of the epigenome.
The function of epigenetic drugs in that they help in reversing these epigenetic changes. Epigenetic therapies are often used in the treatment of solid tumors and other types of cancer.
Key features of the study:
Detailed Segmentation:
Global Epigenetics Drugs & Diagnostic Technologies Market, By Type:
Global Epigenetics Drugs & Diagnostic Technologies Market, By Region:
Company Profiles
Key Topics Covered:
1. Research Objectives and Assumptions
2. Market Purview
3. Market Dynamics, Regulations, and Trends Analysis
4. Global Epigenetic Drugs & Diagnostic Technologies Market – Impact of Coronavirus (Covid-19) Pandemic
5. Global Epigenetic Drugs & Diagnostic Technologies Market, By Type, 2017 – 2030, (US$ Mn)
6. Global Epigenetic Drugs & Diagnostic Technologies Market, By Region, 2017 – 2030, (US$ Mn)
7. Competitive Landscape
8. Section
For more information about this report visit https://www.researchandmarkets.com/r/abngu5
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900